Pfizer Delays COVID Vaccine For Those Under Age 5

PLEASE SHARE

WASHINGTON DC – Pfizer announced today, February 11, that parents will have to wait a little longer for a COVID vaccine for children under age 5.

Pfizer-BioNTech said it is postponing its application to the U.S. Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years.

The company said it still needs more data on the effects of a three-dose vaccine after two doses didn’t create a strong enough immune response.

For infants, toddlers, & preschoolers, Pfizer’s vaccine has a dosage of 3 micrograms.

For children ages 5 to 11, the dosage is higher, at 10 micrograms.

Pfizer asked the FDA this month to authorize these first two doses, with a plan to submit additional data in the coming weeks on a third dose. The full vaccination series would be three doses.

More conclusive research is expected by early April, said Pfizer.

editor

email: editor@FraminghamSource.com call or text at 508-315-7176


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/framin10/public_html/wp-includes/functions.php on line 5275

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/framin10/public_html/wp-content/plugins/really-simple-ssl/class-mixed-content-fixer.php on line 110